EdgeMarket › Instruments › SVA
SVA — SINOVAC BIOTECH LTD
NASDAQ
Healthcare
Pharma & biotech
equity
6.47
+0.00% today
USD · as of 2025-03-21
Price · 2024-08-26 → 2025-03-21
143 daily closes shown52w low 6.47 · high 6.47
Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.
Performance
1 day+0.00%
1 week+0.00%
1 month+0.00%
3 months+0.00%
6 months+0.00%
1 year+0.00%
3 years+0.00%
5 years+0.00%
Technicals
RSI 14100.0
vs 50-day avg+0.00%
vs 200-day avg+0.00%
Volatility 1y0.0%
Max drawdown 1y+0.00%
Daily bars held2,318
History from2016-01-04
Others in Healthcare
Largest institutional holders
| manager | value | shares |
|---|---|---|
| ORBIMED ADVISORS LLC | 184.5M | 2.7M |
| Vivo Capital, LLC | 38.2M | 5.9M |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 106.3K | 16.4K |
| MORGAN STANLEY | 59.2K | 9.1K |
| WELLS FARGO & COMPANY/MN | 31.1K | 4.8K |
| UBS Group AG | 14.4K | 2.2K |
| Neumann Advisory Hong Kong Ltd | 2.0K | 315.6K |
| Horizon Investments, LLC | 673 | 104 |
| HARBOUR INVESTMENTS, INC. | 542 | 83 |
| ROYAL BANK OF CANADA | 0 | 426 |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Ask the AI about SVA
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →